HopeStage
Back to all studies
CompletedNCT01135745

Post-Market Follow-Up of Deep Brain Stimulation for OCD

About this title

Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD PMCF)

Read the official source —
Device studyAges 18+Multiple countries
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Leuven and 7 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study clarity

Study information

Study start dateApril 2010
Recruitment status
Completed
Enrollment listed in the registry
32
Sponsor
MedtronicNeuro
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Switzerland, Belgium, Germany, ...
Age range
Over 18 Years
Official registry ID
NCT01135745
Official title
Show the full official title

Reclaim® Deep Brain Stimulation Therapy for Obsessive-Compulsive Disorder: Post-Market Clinical Follow-up Study (OCD PMCF)

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Leuven, Belgium · Lübeck, Germany · Jerusalem, Israel

5 more locations
  • Milan, Italy
  • Barcelona, Spain
  • Granada, Spain
  • Stockholm, Sweden
  • Bern, Switzerland
FAQ

Questions about this study

Who is behind this study?

The study sponsor is MedtronicNeuro.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies